Skip to main
OTLK
OTLK logo

Outlook Therapeutics Inc (OTLK)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy OTLK Stock

About Outlook Therapeutics Inc (OTLK)

Outlook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of ONS-5010/LYTENAVA. Its pipeline includes unmet patient needs, repackaged IV bevacizumab, and anti-VEGF. The company was founded by Pankaj Mohan on January 5, 2010 and is headquartered in Iselin, NJ.
Market cap$68.57M
Today's volume247.09K
Revenue (TTM)
Avg. daily volume618.53K
EBITDA (TTM)-$76.32M
Open$1.62
Price / earnings ratio-1.12x
Today's range$1.56 - $1.65
Debt / equity
52 week range$0.87 - $9.25
5 year debt / equity54.08x
Beta (LTM)1.09x
Interest coverage-22.71x
Dividend & yield$0.00 (0.00%)
Current ratio0.72x
Ex-dividend date
Next earningsAug 13, 2025
Dividend payable date

OTLK Stock Rating

What analysts recommend for OTLK stock, on a scale from 1(buy) to 5(sell).
Buy
Strong Buy 60%
Buy 20%
Hold 20%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jun 30, 2025, the market cap for OTLK stock is $68.57M

The current P/E ratio for OTLK stock is -1.12

The 52-week high for OTLK stock is $9.25. The current OTLK stock price $undefined is 100.00% below its 52-week high

The 52-week low for OTLK stock is $0.87. The current OTLK stock price $undefined has increased 100.00% from its 52-week low

No, the OTLK stock does not pay dividends to its shareholders

The target price for OTLK stock is $7.26 based on the average of what a group of analyst think OTLK stock could be worth at a future date. This is not a prediction by Public.com

How to buy OTLK stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in OTLK stock

    Navigate to the Explore page. Then, type OTLK into the search bar. When you see OTLK stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased OTLK stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Outlook Therapeutics Inc Stock Earnings

The value each OTLK share was expected to gain vs. the value that each OTLK share actually gained.

OTLK (OTLK) reported Q2 2025 earnings per share (EPS) of -$0.40, beating estimates of -$0.55 by 27.27%. In the same quarter last year, OTLK's earnings per share (EPS) was -$1.55. OTLK is expected to release next earnings on 08/13/2025, with an earnings per share (EPS) estimate of -$0.43.

Buy OTLK Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.